Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin for Primary Generalized Tonic-Clonic Seizures
CTR20150717Phase 3Completed
- Sponsor
- Pfizer
- Start
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pregabalin in primary generalized tonic-clonic seizure (PGTCS), sponsored by Pfizer. Started Apr 2017; status: completed.
02
Drugs
pregabalin
03
Conditions
primary generalized tonic-clonic seizure (PGTCS)
Beyond the preview
Go deeper on CTR20150717.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150717.